Divis Laboratories Ltd | DIVI - Stammkapital





Stammkapital Veränderung Datum
Alaunos Therapeutics USD 2.38M 172K 2026-03
Aurobindo Pharma INR 580.8M 0 2026-03
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 0 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Lupin INR 456.76M 456.44M 2025-09
Moderna USD 391M 2M 2025-09
Organon & Co USD 260.32M 333K 2025-12
Revvity USD 111.8M 1.57M 2026-03
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12